A set of training materials for professionals working in intervention epidemiology, public health microbiology and infection control and hospital hygiene.
Need help with your investigation or report writing? Ask the Expert. Free advice from the professional community.
You can't make decissions on this page's approval status because you have not the owner or an admin on this page's Group.
MDRO pathogens that are frequently been implicated in severe healthcare-associated infections (HAIs) and have important infection control implications are the following:
Table: Antimicrobial categories used to define MDR gram-negative bacteria.
Antipseudomonal cephalosporins (ceftazidime, cefepime)
Antipseudomonal carbapenems (Imipenem, Meropenem, Doripenem)
Carbapenems (Ertapenem, Imipenem, Meropenem, Doripenem)
Antipseudomonal fluoroquinolones (ciprofloxacin, levofloxacin)
Antipseudomonal penicillins + beta-lactamase inhibitors
Antipseudomonal penicillins + beta-lactamase inhibitors (piperacillin/tazobactam, ticarcillin-clavulanic acid)
Extended spectrum cephalosporins (cefotaxime, ceftriaxone, ceftazidime, cefepime)
Folate pathway inhibitors
Penicillins + beta-lactamase inhibitors (ampicillin/sulbactam)
You need to be logged in to post comments.
You can log in here. You can register here if you haven't done so yet.